Skip to main content

Table 1 KEGG Pathways and GO annotation enriched in high-risk and low-risk groups using GSEA

From: TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation

NAME

SIZE

ES

NES

NOM p-val

FDR q-val

FWER p-val

Rank at max

Leading edge

KEGG_HSA04110_CELL_CYCLE

116

−0.4744268

−1.329925

0

0.32765228

1

2757

tags = 45%, list = 22%, signal = 57%

GO_GO:0045931_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE

121

−0.4059705

−1.7015916

0

0.2011301

0.758

1579

tags = 26%, list = 13%, signal = 29%

GO_GO:0002526_ACUTE_INFLAMMATORY_RESPONSE

32

0.55722696

1.6772016

0

0.41694513

0.837

895

tags = 25%, list = 7%, signal = 27%